Why the study?
The study aimed to investigate Optical Genome Mapping as a diagnostic tool for testing FSHD cases from the UK and India and compare its performance with traditional Southern blotting techniques.
Does Optical Genome Mapping accurately diagnose FSHD compared to traditional Southern blotting techniques in suspected and confirmed cases?
Does Optical Genome Mapping accurately diagnose FSHD compared to traditional Southern blotting techniques in suspected and confirmed cases?
Optical Genome Mapping is a valid and promising tool for diagnosing FSHD1, showing high correlation with traditional Southern blotting techniques.
No takes yet. Share an insight, caveat, or question.
May aid FSHD1 diagnosis in complex cases; leaves open routine adoption pending larger validation studies.
Efthymiou et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: